BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23707526)

  • 21. Src-like adaptor protein 2 (SLAP2) binds to and inhibits FLT3 signaling.
    Moharram SA; Chougule RA; Su X; Li T; Sun J; Zhao H; Rönnstrand L; Kazi JU
    Oncotarget; 2016 Sep; 7(36):57770-57782. PubMed ID: 27458164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation.
    Agarwal S; Kazi JU; Rönnstrand L
    J Biol Chem; 2013 Aug; 288(31):22460-8. PubMed ID: 23803604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration.
    Ueda S; Mizuki M; Ikeda H; Tsujimura T; Matsumura I; Nakano K; Daino H; Honda Zi Z; Sonoyama J; Shibayama H; Sugahara H; Machii T; Kanakura Y
    Blood; 2002 May; 99(9):3342-9. PubMed ID: 11964302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of the high-affinity IgE receptor results in the tyrosine phosphorylation of a 60 kD protein which is associated with the protein-tyrosine kinase, Csk.
    Rafnar T; Peebles RS; Brummet ME; Catipović B; Imani F; MacGlashan DW; Marsh DG
    Mol Immunol; 1998 Mar; 35(4):249-57. PubMed ID: 9736341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood CD56(bright) NK cells respond to stem cell factor and adhere to its membrane-bound form after upregulation of c-kit.
    Pradier A; Tabone-Eglinger S; Huber V; Bosshard C; Rigal E; Wehrle-Haller B; Roosnek E
    Eur J Immunol; 2014 Feb; 44(2):511-20. PubMed ID: 24150691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RTK SLAP down: the emerging role of Src-like adaptor protein as a key player in receptor tyrosine kinase signaling.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2015 Feb; 27(2):267-74. PubMed ID: 25446260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes.
    Jo A; Park H; Lee SH; Ahn SH; Kim HJ; Park EM; Choi YH
    PLoS One; 2014; 9(3):e91582. PubMed ID: 24632723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.
    Simon C; Dondi E; Chaix A; de Sepulveda P; Kubiseski TJ; Varin-Blank N; Velazquez L
    Blood; 2008 Nov; 112(10):4039-47. PubMed ID: 18753636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling.
    Kazi JU; Rupar K; Marhäll A; Moharram SA; Khanum F; Shah K; Gazi M; Nagaraj SR; Sun J; Chougule RA; Rönnstrand L
    Oncotarget; 2017 Feb; 8(7):12194-12202. PubMed ID: 28086240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation.
    Rupar K; Moharram SA; Kazi JU; Rönnstrand L
    Sci Rep; 2018 Apr; 8(1):6405. PubMed ID: 29686302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.
    Sun J; Pedersen M; Bengtsson S; Rönnstrand L
    Exp Cell Res; 2007 Nov; 313(18):3935-42. PubMed ID: 17904548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src-Like adaptor protein (SLAP) binds to the receptor tyrosine kinase Flt3 and modulates receptor stability and downstream signaling.
    Kazi JU; Rönnstrand L
    PLoS One; 2012; 7(12):e53509. PubMed ID: 23300935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Csk homologous kinase (CHK), unlike Csk, enhances MAPK activation via Ras-mediated signaling in a Src-independent manner.
    Zagozdzon R; Kaminski R; Fu Y; Fu W; Bougeret C; Avraham HK
    Cell Signal; 2006 Jun; 18(6):871-81. PubMed ID: 16168623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity.
    Plani-Lam JH; Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Singer P; Lam KP; Hibbs ML; Ingley E
    Exp Hematol; 2017 Feb; 46():70-82.e10. PubMed ID: 27751872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2.
    Heiss E; Masson K; Sundberg C; Pedersen M; Sun J; Bengtsson S; Rönnstrand L
    Blood; 2006 Sep; 108(5):1542-50. PubMed ID: 16684964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.
    Liang X; Wisniewski D; Strife A; Shivakrupa ; Clarkson B; Resh MD
    J Biol Chem; 2002 Apr; 277(16):13732-8. PubMed ID: 11825908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
    Senda Y; Murata-Kamiya N; Hatakeyama M
    Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Src family kinases: regulation of their activities, levels and identification of new pathways.
    Ingley E
    Biochim Biophys Acta; 2008 Jan; 1784(1):56-65. PubMed ID: 17905674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase C-δ-mediated recycling of active KIT in colon cancer.
    Park M; Kim WK; Song M; Park M; Kim H; Nam HJ; Baek SH; Kim H
    Clin Cancer Res; 2013 Sep; 19(18):4961-71. PubMed ID: 23881925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive.
    Tabone-Eglinger S; Calderin-Sollet Z; Pinon P; Aebischer N; Wehrle-Haller M; Jacquier MC; Boettiger D; Wehrle-Haller B
    FASEB J; 2014 Oct; 28(10):4441-56. PubMed ID: 25002122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.